BE742073A - Polycatechine medicaments - Google Patents

Polycatechine medicaments

Info

Publication number
BE742073A
BE742073A BE742073DA BE742073A BE 742073 A BE742073 A BE 742073A BE 742073D A BE742073D A BE 742073DA BE 742073 A BE742073 A BE 742073A
Authority
BE
Belgium
Prior art keywords
catechin
sep
complex
epicatechin
desc
Prior art date
Application number
Other languages
English (en)
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE742073A publication Critical patent/BE742073A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/60—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2
    • C07D311/62—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2 with oxygen atoms directly attached in position 3, e.g. anthocyanidins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE742073D 1968-11-22 1969-11-21 Polycatechine medicaments BE742073A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR174899A FR7760M (es) 1968-11-22 1968-11-22

Publications (1)

Publication Number Publication Date
BE742073A true BE742073A (en) 1970-05-21

Family

ID=8657269

Family Applications (1)

Application Number Title Priority Date Filing Date
BE742073D BE742073A (en) 1968-11-22 1969-11-21 Polycatechine medicaments

Country Status (2)

Country Link
BE (1) BE742073A (es)
FR (1) FR7760M (es)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0003274A1 (de) * 1977-11-25 1979-08-08 Zyma SA o-Substituierte Derivate des (+)-Cyanidin-3-ols,Verfahren zu ihrer Herstellung, sowie diese Verbindungen enthaltende pharmazeutische Zusammensetzungen und deren Herstellung
US4507314A (en) * 1983-07-20 1985-03-26 Midit, Societe Fiduciaire Drug for treating affections provoked by a too high histamine level, of the gastroduodenal mucosa and allergic affections
US5318986A (en) * 1989-10-19 1994-06-07 Mitsui Norin Co., Ltd. Method of inhibiting the activity of α-amylase

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0290442A4 (en) * 1986-11-19 1990-07-03 Chemex Pharmaceuticals Inc MEDICINAL PREPARATIONS AND MIXTURES THEREOF, ORGANIC COMPOSITIONS AND METAL SALTS.

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0003274A1 (de) * 1977-11-25 1979-08-08 Zyma SA o-Substituierte Derivate des (+)-Cyanidin-3-ols,Verfahren zu ihrer Herstellung, sowie diese Verbindungen enthaltende pharmazeutische Zusammensetzungen und deren Herstellung
US4507314A (en) * 1983-07-20 1985-03-26 Midit, Societe Fiduciaire Drug for treating affections provoked by a too high histamine level, of the gastroduodenal mucosa and allergic affections
US5318986A (en) * 1989-10-19 1994-06-07 Mitsui Norin Co., Ltd. Method of inhibiting the activity of α-amylase

Also Published As

Publication number Publication date
FR7760M (es) 1970-03-16

Similar Documents

Publication Publication Date Title
Kligman Dimethyl sulfoxide—part 2
US10154977B2 (en) Anti-inflammatory particles
ES2280527T3 (es) Una composicion farmaceutica de jasmonato para tratamiento del cancer.
JPH07509247A (ja) ラパマイシン誘導体
AR065827A2 (es) Formas de dosificacion de liberacion sostenida de sertralina, sales de sertralina, composicion farmaceutica, procedimiento y preparacion y su uso en terapia
JPS6242973A (ja) Ｌ−リジンピルベ−ト及びｌ−ヒスチジンピルベ−ト
ES2911110T3 (es) Combinaciones de tofacitinib y crisaborol para uso en el tratamiento de enfermedades inflamatorias de la piel
US5242905A (en) Pharmaceutical compositions for the treatment of psoriasis
Ross et al. Cycloaliphatic Amino Acids in Cancer Chemotherspy
BE742073A (en) Polycatechine medicaments
CA1340005C (en) Pharmaceutical composition for the treatment of psoriasis
JPH06506212A (ja) Ｈｉｖウイルス系疾病、ヘルペス、色素性網膜炎およびマラリアの治療向けリボフラビンの利用
US5214196A (en) Diethyl ester of di-glycyl fumaramide
ES2509143T3 (es) Tratamiento de una septicemia con 5-etil-1-fenil-2(1H)-piridona
BE726774A (es)
US4824673A (en) New drugs based on extracts of algae, and corresponding formulations
FR2609893A1 (fr) Composition a base d'acides amines et de vitamines utilisable en therapeutique cancerologique
CA2083825A1 (fr) Nouvelle composition pharmaceutique a base de taurine pour l'administration par inhalation
JP2014152171A (ja) 新規生理活性組成物
MXPA06006717A (es) Agentes de combinacion de chp-gencitabina y su uso como agentes anti-tumorales, especialmente como agentes anti-metastatizacion.
FR2702655A1 (fr) Composition thérapeutique nouvelle ayant un effet immunostimulant.
McGinty et al. The ulcer-inhibiting action of pyrogens
US3558600A (en) Alkyl sulfate salts of 1-(p-chlorobenzhydryl)-4-methylhomopiperazines
RU2257197C1 (ru) Вагинальные суппозитории, обладающие контрацептивным действием
TWI841431B (zh) 斯文豪蒂殼海綿萃取物用以製備供選擇性抑制口腔癌細胞生長的藥物的用途

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: SOC. FRANC. DE RECHERCHE MEDICALE

Effective date: 19881130

Owner name: SCIENCE UNION ET CIE

Effective date: 19881130